Extra transparency measures for COVID-19 vaccines and therapeutics

Today the European Medicines Agency (EMA) has implemented two further extra transparency measures for COVID-19 medicines, by publishing both the clinical data in support of the authorisation of Veklury (remdesivir) and information on the COVID-19 treatments and vaccines that have received scientific advice or informal guidance from EMA’s pandemic Task Force (COVID-ETF).

The top five European cities for celebrating Halloween

Halloween is almost upon us and although this year’s celebrations will need to be small gatherings, it’s still a great time to learn about European cultures, traditions, frightening places and haunted castles. Here we explore some of Europe’s top Halloween destinations and how we can still celebrate the scariest night of the year.

Euro area economic and financial developments by institutional sector: second quarter of 2020

Euro area net saving decreased to €625 billion in four quarters to second quarter of 2020, from €775 billion one quarter earlier. The household debt-to-income ratio increased to 94.9% in second quarter of 2020, from 93.4% one year earlier. Non-financial corporations’ debt-to-GDP ratio (consolidated measure) increased to 83.3% in second quarter of 2020, from 78.7% […]

EU solidarity in action: €56.7 million to Spain to repair the damages of the extreme weather DANA in autumn 2019

The European Commission granted aid worth €56.7 million from the EU Solidarity Fund (EUSF) to Spain following the extreme weather conditions DANA (Depresión Aislada en Niveles Altos) resulting in floods in the regions of Valencia, Murcia, Castilla-La Mancha and Andalucia in September 2019.

According to Advocate General Tanchev, the Court should dismiss the appeal of the Commission against the judgment of the General Court on support measures adopted by an Italian consortium of banks for the benefit of one of its members

The General Court was right in considering that those measures did not constitute State aid as they did not entail the use of State resources and were not imputable to the State.

The refusal by a patient’s Member State of affiliation to grant prior authorisation for the reimbursement of cross-border healthcare costs when effective hospital treatment is available in that Member State but the method of treatment used is against the insured person’s religious beliefs brings about a difference in treatment indirectly based on religion

That refusal is not contrary to EU law if it is objectively justified by a legitimate aim relating to maintaining treatment capacity or medical competence and is an appropriate and necessary means of achieving that aim